business units

Business Units

It's an amazing company to me, in that we're very diversified, we have very distinct business units, yet we're very focused as a company. And that focus has always been on patient health.
— Michael Phipps
Staff Scientist
Clinical Immunology
Over the years, Genzyme has focused on several medical areas, while remaining unified by a few key principles: addressing unmet medical needs, exploring innovative technologies and treatment approaches, and improving the lives of patients worldwide.
A Focus on Medical Needs

Genzyme is currently organized into two business units – Rare Diseases and Multiple Sclerosis.

Our business units establish a structure for developing and marketing our products - but Genzyme encourages synergies across the company, and we believe it is this sharing of knowledge, ideas, and resources that leads to our most innovative, life-changing work. By collaborating together, we can fulfill Genzyme’s mission to develop and deliver transformative therapies for patients with unmet medical needs.

Rare Diseases Focusing on uncommon and underserved medical conditions, our Rare Disease business unit develops breakthrough therapies for patients who might otherwise have few treatment options. More
Multiple Sclerosis We are committed to becoming a longterm partner to the MS community by working to deliver scientific advancements that will have a significant impact on the unmet needs of people living with MS. More

Last Updated: 5/13/2015
Contact Us
Genzyme Corporation

500 Kendall Street
Cambridge, MA 02142
T: 617-252-7500
F: 617-252-7600

Send Email
News Subscription

Sign up to get Genzyme's latest press releases delivered to your email:


Explore opportunities at a company that's as committed to our employees as we are to our patients.